Axalbion is Biotechnology in United Kingdom that focus on based therapies business. Founded in 2016. They cover business area such as molecular transducer, treatment, chronic cough, dry eye, new transducer agonist, two lead candidate, abnormal cough, lacrimation, sensory discomfort, doctor.
2016
( 8 years old in 2024 )
Based Therapies
-
Medicines Evaluation Unit
The Langley Building Southmoor Road, Wythenshawe
Manchester M23 9QZ
England, United Kingdom
Private
molecular transducertreatmentchronic coughdry eyenew transducer agonisttwo lead candidateabnormal coughlacrimationsensory discomfortdoctor
* We use standard office opening hours in near Axalbion's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Axalbion is Biotechnology business from United Kingdom that founded in 2016 (8 years old in 2024), Axalbion business is focusing on Based Therapies.
Axalbion headquarter office and corporate office address is located in Medicines Evaluation Unit The Langley Building Southmoor Road, Wythenshawe Manchester M23 9QZ England, United Kingdom.
Axalbion was founded in United Kingdom.
In 2024, Axalbion is currently focus on based therapies sector.
Above is snippet of Google Trends for "based therapies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Axalbion, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
